Skip to content
Catalyst

rosuvastatinPapers

Papers about rosuvastatin

papers
651
26 years, by papers

Newest first

51 to 100 of 651

Every paper here, unless its row says otherwiseReturned by a PubMed search for rosuvastatin

  • Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.

    The Lancet. Infectious diseases2023PMID 36966799

  • Effectiveness and Safety of a Fixed-Dose Combination of Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patients with Concomitant Hypertension and Hyperlipidemia: An Observational Study.

    Drug design, development and therapy2023PMID 37051292

  • Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment.

    Scientific reports2023PMID 37208484

  • The lipid-lowering efficacy of rosuvastatin is associated with variations in SLCO1B1: a 12-month prospective cohort study.

    European review for medical and pharmacological sciences2023PMID 37259755

  • A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.

    American journal of cardiovascular drugs2023PMID 37395974

  • Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial.

    Advances in therapy2023PMID 37770770

  • Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.

    Journal of cardiovascular pharmacology and therapeutics2023PMID 37814541

  • Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial).

    Blood coagulation & fibrinolysis2023PMID 37942744

  • The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study.

    Diabetes & metabolism journal2023PMID 38043782

  • Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases-INVITATION Trial.

    Journal of atherosclerosis and thrombosis2022PMID 33408315

  • Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials.

    Cardiovascular research2022PMID 33705531Also tests rosuvastatin

  • Efficacy evaluation of PCSK9 monoclonal antibody (Evolocumab) in combination with Rosuvastatin and Ezetimibe on cholesterol levels in patients with coronary heart disease (CHD): A retrospective analysis from a single center in China.

    Transplant immunology2022PMID 34375677

  • Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.

    European journal of clinical pharmacology2022PMID 34668025

  • Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study.

    Journal of nuclear cardiology2022PMID 34820771

  • Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial.

    Journal of thrombosis and haemostasis2022PMID 34953155

  • Pharmacokinetics of a new fixed-dose combination of candesartan cilexetil, hydrochlorothiazide, and rosuvastatin in healthy adult subjects.

    International journal of clinical pharmacology and therapeutics2022PMID 35103587

  • Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER).

    Thrombosis research2022PMID 35344784

  • Significant decrease in plasmad-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism.

    Clinical cardiology2022PMID 35481712

  • Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single-dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions.

    Clinical pharmacology in drug development2022PMID 35567420

  • Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients.

    Computational and mathematical methods in medicine2022PMID 35756414

  • Effects of Clostridium butyricum Capsules Combined with Rosuvastatin on Intestinal Flora, Lipid Metabolism, Liver Function and Inflammation in NAFLD Patients.

    Cellular and molecular biology (Noisy-le-Grand, France)2022PMID 35869734

  • Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.

    Stroke2022PMID 36017704

  • Rosuvastatin Intervention Decreased the Frequencies of the TIM-3+ Population of NK Cells and NKT Cells among Patients with Chronic Hepatitis B.

    Iranian journal of immunology2022PMID 36190380

  • The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation.

    Disease markers2022PMID 36284992

  • A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins.

    Journal of cardiovascular pharmacology and therapeutics2022PMID 36420979

  • The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial.

    PloS one2022PMID 36480560

  • Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.

    Infectious diseases (London, England)2021PMID 32955957

  • Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study - preliminary results.

    Cardiology journal2021PMID 33200812

  • Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trial.

    AIDS (London, England)2021PMID 33252480

  • Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects.

    Advances in therapy2021PMID 33326064

  • Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults.

    Clinical pharmacokinetics2021PMID 33428168

  • Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study.

    Journal of acquired immune deficiency syndromes (1999)2021PMID 33620177

  • Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.

    Drug design, development and therapy2021PMID 33628012

  • Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.

    Clinical pharmacology in drug development2021PMID 33647189

  • The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.

    AIDS research and human retroviruses2021PMID 33913752

  • Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk.

    Expert review of clinical pharmacology2021PMID 33970743

  • Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.

    Journal of clinical hypertension (Greenwich, Conn.)2021PMID 34384001

  • Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk.

    The Journal of infectious diseases2021PMID 34398237

  • Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study.

    Clinical therapeutics2021PMID 34429197

  • Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI.

    Journal of interventional cardiology2021PMID 34566523

  • Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.

    PloS one2021PMID 34818350

  • Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease.

    Journal of healthcare engineering2021PMID 34956579

  • Effects of Food and Gender on Pharmacokinetics of Rosuvastatin in a Chinese Population Based on 4 Bioequivalence Studies.

    Clinical pharmacology in drug development2020PMID 31148412

  • High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion.

    International journal of cardiology2020PMID 31409515

  • Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin, Formulation and Food on Oral Bioavailability.

    Clinical pharmacology in drug development2020PMID 31793171

  • Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia.

    European journal of gastroenterology & hepatology2020PMID 31895906

  • Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.

    BMC medicine2020PMID 31948461

  • Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia.

    Clinical and translational science2020PMID 31981411

  • A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.

    Journal of clinical hypertension (Greenwich, Conn.)2020PMID 32003938

  • A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.

    Scientific reports2020PMID 32020028

The next 50 papers

← Previous 50